Viewing Study NCT01863459


Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2026-01-11 @ 10:18 PM
Study NCT ID: NCT01863459
Status: COMPLETED
Last Update Posted: 2017-08-02
First Post: 2013-05-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity
Sponsor: Centre for Anxiety, Attention Deficit and Trauma, Ontario, Canada
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: LDX-COMORB-1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View